Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
13.11
+0.35 (2.70%)
Aug 13, 2025, 4:00 PM - Market closed
Cross Country Healthcare Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Cross Country Healthcare stock ranges from a low of $16.5 to a high of $18.61. The average analyst price target of $17.93 forecasts a 36.82% increase in the stock price over the next year.
Price Target: $17.93 (+36.82%)
Analyst Consensus: Hold
* Price targets were last updated on Jun 17, 2025.
Analyst Ratings
The average analyst rating for Cross Country Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +42.01% | Jun 17, 2025 |
UBS | UBS | Hold Maintains $19 → $17 | Hold | Maintains | $19 → $17 | +25.91% | May 13, 2025 |
Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +42.01% | Mar 14, 2025 |
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 6, 2025 |
Barrington Research | Barrington Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 10, 2024 |
Financial Forecast
Revenue This Year
1.20B
from 1.34B
Decreased by -10.71%
Revenue Next Year
1.27B
from 1.20B
Increased by 5.58%
EPS This Year
0.31
from -0.44
EPS Next Year
0.49
from 0.31
Increased by 58.65%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 1.3B | 1.3B | 1.4B |
Avg | 1.2B | 1.3B | 1.4B |
Low | 1.1B | 1.2B | 1.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | -5.3% | 12.3% | 10.9% |
Avg | -10.7% | 5.6% | 7.7% |
Low | -15.5% | -0.6% | 3.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.53 | 0.71 | 0.63 |
Avg | 0.31 | 0.49 | 0.61 |
Low | 0.18 | 0.35 | 0.59 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | 129.0% | 27.3% |
Avg | - | 58.6% | 23.7% |
Low | - | 13.1% | 18.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.